C-Reactive Protein levels in Acute Stroke: Ischemic vs Hemorrhagic in a Tertiary Care Hospital: CRP levels in acute stroke

Nighat  Jamal; Iqra  Jadoon; Ameer  Hamza; Syed  Affan Ali; Abdur  Rauf; Hassan  Mumtaz; Syed Muhammad Ismail

doi:10.54393/pbmj.v5i6.513

Authors

Nighat Jamal AMC, Abbotabad
Iqra Jadoon AMC, Abbotabad
Ameer Hamza AMC, Abbotabad
Syed Affan Ali AMC, Abbotabad
Abdur Rauf Ayub Medical College Abbottabad
Hassan Mumtaz Health Services Academy, Islamabad
Syed Muhammad Ismail Dow University of Medical Sciences

DOI:

https://doi.org/10.54393/pbmj.v5i6.513

Keywords:

CRP, Acute Stroke, Hemorrhage, Ischemia

Abstract

There is growing evidence of the prognostic importance of C-reactive protein (CRP) in ischemic stroke. However, the independent value of CRP in ischemic vs hemorrhagic stroke has not been established. Objective: To assess the diagnostic value of CRP as biomarker in ischemic stroke in comparison to hemorrhagic stroke Methods: This prospective study was conducted from March 2020 to March 2022 in the Department of Medicine, Ayub Medical College. Sample size of 71 was calculated including patients of both genders having age 22-105 years admitted with first-ever acute stroke within the first 24 hours of onset. Data was analyzed using SPSS latest version. Quantitative variables are shown as frequency and percentages. Paired T Test was applied to see the association of CRP levels with effect on CT- Scan of Brain. p value less than 0.05 was considered significant Results: 69% of the participants were women, far outnumbering the men. 45 patients found to have ischemic stroke (63.38%) whereas 26 (36.62%) reported having Hemorrhagic stroke. Paired t test applied to see the association of CRP Levels with CT Scan Brain was found significant having p value 0.002 Conclusions: CRP levels are important in the diagnosis of stroke based on data. CRP levels must be compared to those of other stroke biomarkers in order to make this determination. The serum CRP level within 24 hours can be used to predict severity in ischemic but not hemorrhagic stroke.

References

den Hertog HM, van Rossum JA, van der Worp HB, et al. C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. J Neurol. 2009 Dec;256(12):2003-8. doi: 10.1007/s00415-009-5228-x.

Bernstein J E, Savla P, Dong F, et al. (October 31, 2018) Inflammatory Markers and Severity of Intracerebral Hemorrhage. Cureus 10(10): e3529. doi:10.7759/cureus.3529

Matsuo R, Ago T, Hata J, Wakisaka Y, Kuroda J, Kuwashiro T, et al. Plasma C-Reactive Protein and Clinical Outcomes after Acute Ischemic Stroke: A Prospective Observational Study. PLoS ONE, 2016,11(6): e0156790. https://doi.org/10.1371/journal.pone.0156790

Cucchiara BL, Messe SR, Sansing L, MacKenzie L, Taylor RA, Pacelli J, et al. Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA. Stroke. 2009; 40: 2332–2336.

Fang C, Lou B, Zhou J, et al. Blood biomarkers in ischemic stroke: Role of biomarkers in differentiation of clinical phenotype. European Journal of Inflammation. January 2018. doi:10.1177/2058739218780058

Mehta RH, Rathore SS, Radford MJ, Wang Y, Wang Y, Krumholz HM. Acute myocardial infarction in the elderly: differences by age. Journal of the American College of Cardiology. 2001 Sep;38(3):736-41.

Asiimwe D, Mauti GO, Kiconco R. Prevalence and risk factors associated with type 2 diabetes in elderly patients aged 45-80 years at Kanungu District. Journal of diabetes research. 2020 Oct;2020.

R Robles N, F Macias J. Hypertension in the elderly. Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Cardiovascular & Hematological Agents). 2014 Dec 1;12(3):136-45.

Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension. 2001 May;37(5):1199-208.

Di Napoli M, Slevin M, Popa-Wagner A, Singh P, Lattanzi S, Divani AA. Monomeric C-reactive protein and cerebral hemorrhage: from bench to bedside. Frontiers in immunology. 2018:1921.

Zhou Y, Han W, Gong D, Man C, Fan Y. Hs-CRP in stroke: a meta-analysis. Clinica chimica acta. 2016 Jan 30;453:21-7.

Erdal GS, Hursitoglu M, Erdogan HA, Yildirim G, Yayla V, Issever H, Isiksacan N, Kural A, Cirak M, Kansu AD, Karandere F. Serum C-Reactive Protein and Sex Hormone Levels in the Early Hyperacute Phase of Stroke. Clinical Laboratory. 2021 Feb 1;67(2).

Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Critical reviews in clinical laboratory sciences. 2011 Aug 1;48(4):155-70.

Moua ED, Hu C, Day N, Hord NG, Takata Y. Coffee consumption and c-reactive protein levels: A systematic review and meta-analysis. Nutrients. 2020 May;12(5):1349.

Hong I, Karmarkar A, Chan W, et al. Discharge Patterns for Ischemic and Hemorrhagic Stroke Patients Going From Acute Care Hospitals to Inpatient and Skilled Nursing Rehabilitation. Am J Phys Med Rehabil. 2018 Sep;97(9):636-645.

Jiang J, Tan C, Zhou W, et al. Plasma C-Reactive Protein Level and Outcome of Acute Ischemic Stroke Patients Treated by Intravenous Thrombolysis: A Systematic Review and Meta-Analysis. Eur Neurol. 2021;84(3):145-150. doi: 10.1159/000514099.

Pinniboyana VK, Pinniboyana SH, Gridhati S. A study of C-reactive protein in cerebrovascular accident (stroke) in a tertiary care hospital. European Journal of Molecular & Clinical Medicine. 2022, 9(1).

Wang D, Wang J, Li Z, Gu H, Yang K, Zhao X, Wang Y. C-Reaction Protein and the Severity of Intracerebral Hemorrhage: A Study from Chinese Stroke Center Alliance. Neurol Res. 2022 Apr;44(4):285-290. doi: 10.1080/01616412.2021.1980842.

Andersson J, Johansson L, Ladenvall P, Wiklund PG, Stegmayr B, Jern C, Boman K. C-reactive protein is a determinant of first-ever stroke: prospective nested case-referent study. Cerebrovasc Dis. 2009;27(6):544-51. doi: 10.1159/000214217.

Hong SI, Kim JS, Bae HJ, Kim WY. C-reactive Protein for Stroke Detection in the Emergency Department in Patients With Dizziness Without Neurological Deficits. Front Neurol. 2021 May 31;12:662510. doi: 10.3389/fneur.2021.662510.